Methotrexate (MTX) is now the most popular drug worldwide for the treatment of rheumatoid arthritis. Low-dose, weekly MTX (10 to 25 mg/wk) used as either monotherapy or in combination with other drugs has a superior efficacy profile as defined in placebo-controlled trials and comparable efficacy to other drugs including anti-TNF therapy. At 1 year, one third of patients on MTX have no radiographic progression and even greater effects are seen when combined with targeted biological therapies.
This report elaborates the market size, market characteristics, and market growth of the Methotrexate industry, and breaks down according to the type, application, and consumption area of Methotrexate. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Methotrexate in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Methotrexate market covered in Chapter 13:
Huiyu
Qualitestrx (DAVA Pharmaceuticals)
Maoxiang
Teva Pharmaceutical Industries
Antares Pharma
Roxane Laboratories
Pfizer
LingNan Pharmaceutical
Sine
Medac Pharma, Inc.
Powerdone
Silvergate Pharmaceuticals, Inc.

In Chapter 6, on the basis of types, the Methotrexate market from 2015 to 2025 is primarily split into:
Oral
Injection

In Chapter 7, on the basis of applications, the Methotrexate market from 2015 to 2025 covers:
Immune Disease
Cancers
Other Diseases

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025